PAYDENS GROUP HOLDINGS LIMITED

• ◆

  2 PSCs ceased in last 24 months

  Significant control changed hands — see the Ownership section.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +25.9%

  £159,416,191 → £200,638,259

• Cash

  -73.4%

  £3,606,921 → £960,948

• Net assets

  -88.3%

  £17,435,967 → £2,040,831

• Employees

  +17.1%

  1,418 → 1,660

• Operating profit

  +19.8%

  -£12,870,288 → -£10,321,809

• Profit before tax

  +9.9%

  -£17,080,416 → -£15,395,136

• Wages

  +12.8%

  £33,643,635 → £37,958,380

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. PAYDENS GROUP HOLDINGS LIMITED 2010-06-29 → present
2. PAYDENS GH LIMITED 2010-03-24 → 2010-06-29

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Crowe U.K. LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Having taken into account the current and expected levels of government funding in the sector, alongside the planned and realised cost savings within the business, the Directors consider it appropriate to present these financial statements on a going concern basis.”

Group structure

1. PAYDENS GROUP HOLDINGS LIMITED · parent
   1. Paydens Limited 100% · Operator of retail pharmacies
   2. Sangers (Maidstone) Limited 100% · Wholesale supply of pharmaceutical goods
   3. Canterbury Pharmacies Limited 100% · Dormant
   4. SG Court Limited 100% · Dormant
   5. Guidebrook Limited 100% · Dormant
   6. Boldasset Limited 100% · Dormant
   7. Alphacrest Limited 100% · Dormant
   8. Paydens (Steyning) Limited 100% · Dormant
   9. RH Ferries (Romney Marsh) Limited 100% · Dormant
   10. Spensley Services Limited 100% · Dormant
   11. Clementine Associates Limited 100% · Dormant
   12. A&S Shillam Limited 100% · Dormant
   13. Worthing Pharmacies Limited 100% · Dormant
   14. Longprofit Limited 100% · Dormant
   15. Sprint 1159 Limited 100% · Dormant
   16. Thompson's Chemists Limited 100% · Dormant
   17. Boughton Parade Management Limited 56% · Management of real estate on a fee or contract basis

Significant events

• “Post year end, this was successfully renegotiated with HSBC, securing a £15m revolving credit facility (following repayment of the term facility during 2025/26). This facility terminates on 31 March 2027 and provide a solid foundation for our ongoing operations.”
• “Post year-end the group has sold certain pharmacies in line with the agreed plan with the bank and the cash raised has been used in part to further reduce the Group's debt as shown by the reduction in the term facility with HSBC. In the short to medium term, the Directors intend to continue the strategic divestment plan in order to further reduce the Group's overall indebtedness.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

13

last 12 months

Capital events

1

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.